摘要: Die Ubergangsphase aus dem fortpflanzungsfahigen Alter der Frau in die Phase Erschopfung generativen Funktion und Ostrogensekretion des Ovars bezeichnet man als Klimakterium. In dieser Lebensphase liegt Zeitpunkt letzten funktionellen Blutung, Menopause, ein – biologisch gesehen relativ willkurlicher Zeitpunkt, da hier lediglich eine kritische Schwelle uterinen Ostrogenstimulation unterschritten wird, erst 1 Jahr nach Blutung bestimmt werden kann. Perimenopause ist jeweils etwa dauernde unmittelbar vor Menopause. Postmenopause Zeitraum Menopause; ersten 5 postmenopausalen Jahre auch fruhe bezeichnet. Zeitspanne ab 65. Lebensjahr nennt Senium.
springer.com
sci-hub.st 参考文章(47)
L. Holmberg, O.-E. Iversen, C. M. Rudenstam, M. Hammar, E. Kumpulainen, J. Jaskiewicz, J. Jassem, D. Dobaczewska, H. E. Fjosne, O. Peralta, R. Arriagada, M. Holmqvist, J. Maenpa, , Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors Journal of the National Cancer Institute. ,vol. 100, pp. 475- 482 ,(2008) , 10.1093/JNCI/DJN058
D Grady, Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstetrics & Gynecology. ,vol. 97, pp. 116- 120 ,(2001) , 10.1016/S0029-7844(00)01115-7
Nicholas J Raine-Fenning, Mark P Brincat, Yves Muscat-Baron, Skin Aging and Menopause American Journal of Clinical Dermatology. ,vol. 4, pp. 371- 378 ,(2003) , 10.2165/00128071-200304060-00001
Stephen Hulley, Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women JAMA. ,vol. 280, pp. 605- 613 ,(1998) , 10.1001/JAMA.280.7.605
H.G. Burger, G.E. Hale, D.M. Robertson, L. Dennerstein, A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project Human Reproduction Update. ,vol. 13, pp. 559- 565 ,(2007) , 10.1093/HUMUPD/DMM020
Claudia M. Greiser, Eberhard M. Greiser, Martina Dören, Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis Human Reproduction Update. ,vol. 13, pp. 453- 463 ,(2007) , 10.1093/HUMUPD/DMM012
Claudio N Soares, Menopausal transition and depression: who is at risk and how to treat it? Expert Review of Neurotherapeutics. ,vol. 7, pp. 1285- 1293 ,(2007) , 10.1586/14737175.7.10.1285
Christien Weenen, Joop SE Laven, Anne RM Von Bergh, Mark Cranfield, Nigel P Groome, Jenny A Visser, Piet Kramer, Bart CJM Fauser, Axel PN Themmen, Anti‐Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Molecular Human Reproduction. ,vol. 10, pp. 77- 83 ,(2004) , 10.1093/MOLEHR/GAH015
Jacques E. Rossouw, Ross L. Prentice, JoAnn E. Manson, LieLing Wu, David Barad, Vanessa M. Barnabei, Marcia Ko, Andrea Z. LaCroix, Karen L. Margolis, Marcia L. Stefanick, Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause JAMA. ,vol. 297, pp. 1465- 1477 ,(2007) , 10.1001/JAMA.297.13.1465
Rosemary Basson, Sandra Leiblum, Lori Brotto, Leonard Derogatis, Jean Fourcroy, Kerstin Fugl‐Meyer, Alessandra Graziottin, Julia R. Heiman, Ellen Laan, Cindy Meston, Leslie Schover, Jacques Van Lankveld, Willibrord Weijmar Schultz, Revised Definitions of Women's Sexual Dysfunction The Journal of Sexual Medicine. ,vol. 1, pp. 40- 48 ,(2004) , 10.1111/J.1743-6109.2004.10107.X